中文名:SB 202190,p38 MAPK抑制剂
英文名:SB 202190
中文别名:4-(4-氟苯基)-2-(4-羟基苯基)-5-(4-吡啶基)-1H-咪唑
英文别名:152121-30-7|SB 202190|SB202190|SB-202190|FHPI|4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-imidazole|SB202190 (FHPI)|4-(4-(4-fluorophenyl)-5-(pyridin-4-yl)-1H-imidazol-2-yl)phenol|4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole|CH
纯度:99%
货号:S134307
包装:25mg、100mg、5mg
Cas号:152121-30-7
存储温度:2-8°C储存
产品介绍:
SB 202190 is a pyridinyl imidazole that inhibits the p38 pathway. The compound inhibits the isoforms p38α and p38β. SB 202190 has displayed the ability to activate CPP32-like caspases and induce apoptosis. Research demonstrates that when one residue of ERK2, a related p38 not inhibited by pyridinyl imidazoles, is changed it allows SB 202190 to bind. Studies have revealed that SB 202190 can improve leukemia cell growth by activating MEK/MAPK, as well as phosphorylate and activate MLK3.An inhibitor of the isoforms p38α and p38β.
查看阿拉丁官网此产品相关对应页面:https://www.aladdin-e.com/zh_cn/S134307.html
上海阿拉丁生化科技股份有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
阿拉丁客服